Literature DB >> 22531121

Comparison between the gastric cancer cell line MKN-45 and the high-potential peritoneal dissemination gastric cancer cell line MKN-45P.

Atsuhiko Koga1, Keishiro Aoyagi, Takuya Imaizumi, Motoshi Miyagi, Kazuo Shirouzu.   

Abstract

Peritoneal metastasis is the most common form of recurrence in gastric cancer, and is associated with a poor prognosis. It is clear that many agents are involved at the various stages of this process, however, many aspects of the progression remain unclear. In the present study we compared the gastric cancer cell line MKN-45 with the high-potential peritoneal dissemination gastric cancer cell line MKN-45P, established from MKN-45. The supernatant of culture medium of MKN-45 cells or MKN-45P cells was collected, and the concentrations of interleukin-1β (IL-1β), IL-6, IL-8, hepatocyte growth factor (HGF), Transforming growth factor beta-β1 (TGF-β1), vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2), MMP-9, and tissue inhibitor of metalloproteinase-1 (TIMP-1) proteins were measured using an enzyme-linked immuno sorbent assay (ELISA) method. Invasion, wound healing and adhesion assays were performed in vitro to examine interstitial invasion, migration and adhesion in the gastric cancer cell lines. Moreover, Western blotting was performed to determine the expression of cyclooxygenase-1 (COX-1) and COX-2 proteins in the culture media of the cell lines. The concentrations of IL-6, IL-8, VEGF and MMP-2 protein in the culture supernatant of MKN-45P were significantly higher than those of MKN-45. Percent adhesion of MKN-45P was significantly higher than that of MKN-45 in the fibronectin-coated group. There was no significant difference in invasion or migration between MKN-45 and MKN-45P. COX-1 and COX-2 proteins were observed in both cell lines. These results suggested that secretion of IL-6, IL-8, VEGF and MMP-2 from cancer cells, and adhesion of cancer cells to fibronectin, were related to the establishment of peritoneal dissemination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22531121     DOI: 10.2739/kurumemedj.58.73

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  10 in total

1.  iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.

Authors:  Lorena Simón-Gracia; Hedi Hunt; Pablo Scodeller; Jens Gaitzsch; Venkata Ramana Kotamraju; Kazuki N Sugahara; Olav Tammik; Erkki Ruoslahti; Giuseppe Battaglia; Tambet Teesalu
Journal:  Biomaterials       Date:  2016-07-20       Impact factor: 12.479

2.  A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.

Authors:  Kazuki N Sugahara; Pablo Scodeller; Gary B Braun; Tatiana Hurtado de Mendoza; Chisato M Yamazaki; Michael D Kluger; Joji Kitayama; Edwin Alvarez; Stephen B Howell; Tambet Teesalu; Erkki Ruoslahti; Andrew M Lowy
Journal:  J Control Release       Date:  2015-06-11       Impact factor: 9.776

3.  Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.

Authors:  Emily Wonder; Lorena Simón-Gracia; Pablo Scodeller; Ramsey N Majzoub; Venkata Ramana Kotamraju; Kai K Ewert; Tambet Teesalu; Cyrus R Safinya
Journal:  Biomaterials       Date:  2018-03-02       Impact factor: 12.479

4.  Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.

Authors:  Hedi Hunt; Lorena Simón-Gracia; Allan Tobi; Venkata Ramana Kotamraju; Shweta Sharma; Mait Nigul; Kazuki N Sugahara; Erkki Ruoslahti; Tambet Teesalu
Journal:  J Control Release       Date:  2017-06-08       Impact factor: 9.776

5.  Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.

Authors:  Hideki Ikemoto; Prakash Lingasamy; Anne-Mari Anton Willmore; Hedi Hunt; Kaarel Kurm; Olav Tammik; Pablo Scodeller; Lorena Simón-Gracia; Venkata Ramana Kotamraju; Andrew M Lowy; Kazuki N Sugahara; Tambet Teesalu
Journal:  Tumour Biol       Date:  2017-05

Review 6.  Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.

Authors:  James R W McMullen; Matthew Selleck; Nathan R Wall; Maheswari Senthil
Journal:  Oncotarget       Date:  2017-06-27

7.  Identification of An mtDNA Setpoint Associated with Highest Levels of CD44 Positivity and Chemoresistance in HGC-27 and MKN-45 Gastric Cancer Cell Lines.

Authors:  Gökhan Terzioğlu; Özlem Türksoy; Ömer Faruk Bayrak
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

8.  Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.

Authors:  Lorena Simón-Gracia; Hedi Hunt; Pablo D Scodeller; Jens Gaitzsch; Gary B Braun; Anne-Mari A Willmore; Erkki Ruoslahti; Giuseppe Battaglia; Tambet Teesalu
Journal:  Mol Cancer Ther       Date:  2016-02-15       Impact factor: 6.261

Review 9.  Biomarkers of gastric cancer: Current topics and future perspective.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

10.  Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.

Authors:  Shumei Song; Yan Xu; Longfei Huo; Shuangtao Zhao; Ruiping Wang; Yuan Li; Ailing W Scott; Melissa Pool Pizzi; Ying Wang; Yibo Fan; Kazuto Harada; Jiankang Jin; Lang Ma; Xiaodan Yao; Namita D Shanbhag; Qiong Gan; Sinchita Roy-Chowdhuri; Brian D Badgwell; Zhenning Wang; Linghua Wang; Jaffer A Ajani
Journal:  J Exp Clin Cancer Res       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.